Back to shop
TB500 (Thymosin Beta-4) - 10mg
Healing & Immunity

TB500 (Thymosin Beta-4) - 10mg

10mg / Lyophilized *MUST BE RECONSTITUTED* Introducing TB-500 Peptide – Also known as Thymosin Beta 4 or TB-4, this synthetic peptide mirror

$100

10mg / Lyophilized *MUST BE RECONSTITUTED* Introducing TB-500 Peptide – Also known as Thymosin Beta 4 or TB-4, this synthetic peptide mirrors the natural protein Thymosin beta 4, offering researchers a promising avenue for exploration. With properties akin to its natural counterpart, TB-500 may play a role in inducing angiogenesis, accelerating wound healing, and even influencing aspects like tumor cell metastasis and hair growth. This 43 amino acid-containing peptide boasts high solubility in water and a lightweight structure. Abundant in wound fluid, particularly in the company of multiple blood platelets, TB-500 holds the potential for anti-inflammatory effects. It may not only support neurological healing but also contribute to the healing processes in critical areas such as the spinal cord, heart, and dermis.

Important Research Notice

Research use only. Not for human consumption. This product is intended solely for laboratory research and educational applications. It is not designed for use in the diagnosis, treatment, cure, or prevention of any disease or medical condition. By purchasing this product, you acknowledge that this product is intended for research use only and agree to use it in accordance with all applicable laws and regulations.

References

  1. TB500 (Thymosin Beta-4) - 10mg - Peptide Center guide
  2. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applicationsExpert opinion on biological therapy, 2012
  3. Thymosin β(4) and β(10) Expression in Human Organs during Development: A ReviewCells, 2024
  4. Thymosin β4 Promotes Dermal HealingVitamins and hormones, 2016
  5. Thymosin beta 4-like peptidesMethods in enzymology, 1985
  6. Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapiesInternational immunopharmacology, 2023
  7. Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendationsExpert opinion on biological therapy, 2018